On Tuesday, March 31, 2026, CAPA hosted the “Getting on a Biologic Medication“ webinar. This session explored the journey and steps involved in starting a biologic medication for arthritis—from the initial conversation with a rheumatologist about treatment options to...
Have you considered or been approached about switching from a biologic to a biosimilar for helping manage your inflammatory arthritis? This video about biosimilars may help you understand more about biologics and biosimilars and to have a conversation with your...
Are you considering talking to your healthcare provider about biosimilars or has your healthcare provider talked to you already about biosimilars? As people who live with arthritis, we put together some questions reviewed by our Medical Advisory Committee that might...
There are a number of biosimilar medications available to treat people with arthritis in Canada. A biosimilar is a biologic drug that is highly similar to a biologic drug that was already authorized for sale. Health Canada has recently updated its fact sheet on...
CAPA regularly updates this page on biosimilars (previously called subsequent entry biologics or SEBs). Below is our position paper and video to help you understand this type of medication. CAPA’s Video on Biosimilars We have created the video below to help...
English 
Français du Canada